IBDEI0CV ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32287,1,3,0)
 ;;=3^BCC Skin Right Upper Eyelid,Including Canthus
 ;;^UTILITY(U,$J,358.3,32287,1,4,0)
 ;;=4^C44.1121
 ;;^UTILITY(U,$J,358.3,32287,2)
 ;;=^5157257
 ;;^UTILITY(U,$J,358.3,32288,0)
 ;;=D23.122^^97^1327^25
 ;;^UTILITY(U,$J,358.3,32288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32288,1,3,0)
 ;;=3^Benign Neop Skin Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,32288,1,4,0)
 ;;=4^D23.122
 ;;^UTILITY(U,$J,358.3,32288,2)
 ;;=^5157293
 ;;^UTILITY(U,$J,358.3,32289,0)
 ;;=D23.121^^97^1327^27
 ;;^UTILITY(U,$J,358.3,32289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32289,1,3,0)
 ;;=3^Benign Neop Skin Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,32289,1,4,0)
 ;;=4^D23.121
 ;;^UTILITY(U,$J,358.3,32289,2)
 ;;=^5157292
 ;;^UTILITY(U,$J,358.3,32290,0)
 ;;=D23.112^^97^1327^31
 ;;^UTILITY(U,$J,358.3,32290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32290,1,3,0)
 ;;=3^Benign Neop Skin Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,32290,1,4,0)
 ;;=4^D23.112
 ;;^UTILITY(U,$J,358.3,32290,2)
 ;;=^5157291
 ;;^UTILITY(U,$J,358.3,32291,0)
 ;;=D23.111^^97^1327^33
 ;;^UTILITY(U,$J,358.3,32291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32291,1,3,0)
 ;;=3^Benign Neop Skin Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,32291,1,4,0)
 ;;=4^D23.111
 ;;^UTILITY(U,$J,358.3,32291,2)
 ;;=^5157290
 ;;^UTILITY(U,$J,358.3,32292,0)
 ;;=C44.1191^^97^1327^7
 ;;^UTILITY(U,$J,358.3,32292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32292,1,3,0)
 ;;=3^BCC Skin Left Upper Eyelid,Including Canthus
 ;;^UTILITY(U,$J,358.3,32292,1,4,0)
 ;;=4^C44.1191
 ;;^UTILITY(U,$J,358.3,32292,2)
 ;;=^5157259
 ;;^UTILITY(U,$J,358.3,32293,0)
 ;;=C44.1122^^97^1327^12
 ;;^UTILITY(U,$J,358.3,32293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32293,1,3,0)
 ;;=3^BCC Skin Right Lower Eyelid,Including Canthus
 ;;^UTILITY(U,$J,358.3,32293,1,4,0)
 ;;=4^C44.1122
 ;;^UTILITY(U,$J,358.3,32293,2)
 ;;=^5157258
 ;;^UTILITY(U,$J,358.3,32294,0)
 ;;=L92.0^^97^1328^1
 ;;^UTILITY(U,$J,358.3,32294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32294,1,3,0)
 ;;=3^Granuloma Annulare
 ;;^UTILITY(U,$J,358.3,32294,1,4,0)
 ;;=4^L92.0
 ;;^UTILITY(U,$J,358.3,32294,2)
 ;;=^184052
 ;;^UTILITY(U,$J,358.3,32295,0)
 ;;=D18.01^^97^1329^1
 ;;^UTILITY(U,$J,358.3,32295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32295,1,3,0)
 ;;=3^Hemangioma of Skin/Subcutaneous Tissue
 ;;^UTILITY(U,$J,358.3,32295,1,4,0)
 ;;=4^D18.01
 ;;^UTILITY(U,$J,358.3,32295,2)
 ;;=^267697
 ;;^UTILITY(U,$J,358.3,32296,0)
 ;;=L68.0^^97^1329^2
 ;;^UTILITY(U,$J,358.3,32296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32296,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,32296,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,32296,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,32297,0)
 ;;=L68.9^^97^1329^5
 ;;^UTILITY(U,$J,358.3,32297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32297,1,3,0)
 ;;=3^Hypertrichosis,Unspec
 ;;^UTILITY(U,$J,358.3,32297,1,4,0)
 ;;=4^L68.9
 ;;^UTILITY(U,$J,358.3,32297,2)
 ;;=^5009267
 ;;^UTILITY(U,$J,358.3,32298,0)
 ;;=L74.510^^97^1329^3
 ;;^UTILITY(U,$J,358.3,32298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32298,1,3,0)
 ;;=3^Hyperhidrosis,Primary,Focal,Axilla
 ;;^UTILITY(U,$J,358.3,32298,1,4,0)
 ;;=4^L74.510
 ;;^UTILITY(U,$J,358.3,32298,2)
 ;;=^5009290
 ;;^UTILITY(U,$J,358.3,32299,0)
 ;;=L81.4^^97^1329^4
 ;;^UTILITY(U,$J,358.3,32299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32299,1,3,0)
 ;;=3^Hyperpigmentation,Other
 ;;^UTILITY(U,$J,358.3,32299,1,4,0)
 ;;=4^L81.4
 ;;^UTILITY(U,$J,358.3,32299,2)
 ;;=^5009314
 ;;^UTILITY(U,$J,358.3,32300,0)
 ;;=L91.0^^97^1329^6
 ;;^UTILITY(U,$J,358.3,32300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32300,1,3,0)
 ;;=3^Hypertrophic Scar
 ;;^UTILITY(U,$J,358.3,32300,1,4,0)
 ;;=4^L91.0
 ;;^UTILITY(U,$J,358.3,32300,2)
 ;;=^5009459
 ;;^UTILITY(U,$J,358.3,32301,0)
 ;;=L91.8^^97^1329^7
 ;;^UTILITY(U,$J,358.3,32301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32301,1,3,0)
 ;;=3^Hypertrophic Skin Disorders
 ;;^UTILITY(U,$J,358.3,32301,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,32301,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,32302,0)
 ;;=L90.0^^97^1330^14
 ;;^UTILITY(U,$J,358.3,32302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32302,1,3,0)
 ;;=3^Lichen Sclerosus et Atrophicus
 ;;^UTILITY(U,$J,358.3,32302,1,4,0)
 ;;=4^L90.0
 ;;^UTILITY(U,$J,358.3,32302,2)
 ;;=^70699
 ;;^UTILITY(U,$J,358.3,32303,0)
 ;;=L28.0^^97^1330^15
 ;;^UTILITY(U,$J,358.3,32303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32303,1,3,0)
 ;;=3^Lichen Simplex Chronicus
 ;;^UTILITY(U,$J,358.3,32303,1,4,0)
 ;;=4^L28.0
 ;;^UTILITY(U,$J,358.3,32303,2)
 ;;=^259859
 ;;^UTILITY(U,$J,358.3,32304,0)
 ;;=L66.1^^97^1330^11
 ;;^UTILITY(U,$J,358.3,32304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32304,1,3,0)
 ;;=3^Lichen Planopilaris
 ;;^UTILITY(U,$J,358.3,32304,1,4,0)
 ;;=4^L66.1
 ;;^UTILITY(U,$J,358.3,32304,2)
 ;;=^5009253
 ;;^UTILITY(U,$J,358.3,32305,0)
 ;;=L43.0^^97^1330^12
 ;;^UTILITY(U,$J,358.3,32305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32305,1,3,0)
 ;;=3^Lichen Planus,Hypertrophic
 ;;^UTILITY(U,$J,358.3,32305,1,4,0)
 ;;=4^L43.0
 ;;^UTILITY(U,$J,358.3,32305,2)
 ;;=^5009178
 ;;^UTILITY(U,$J,358.3,32306,0)
 ;;=L43.2^^97^1330^16
 ;;^UTILITY(U,$J,358.3,32306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32306,1,3,0)
 ;;=3^Lichenoid Drug Reaction
 ;;^UTILITY(U,$J,358.3,32306,1,4,0)
 ;;=4^L43.2
 ;;^UTILITY(U,$J,358.3,32306,2)
 ;;=^5009180
 ;;^UTILITY(U,$J,358.3,32307,0)
 ;;=L43.9^^97^1330^13
 ;;^UTILITY(U,$J,358.3,32307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32307,1,3,0)
 ;;=3^Lichen Planus,Unspec
 ;;^UTILITY(U,$J,358.3,32307,1,4,0)
 ;;=4^L43.9
 ;;^UTILITY(U,$J,358.3,32307,2)
 ;;=^5009183
 ;;^UTILITY(U,$J,358.3,32308,0)
 ;;=L93.0^^97^1330^18
 ;;^UTILITY(U,$J,358.3,32308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32308,1,3,0)
 ;;=3^Lupus,Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,32308,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,32308,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,32309,0)
 ;;=L93.2^^97^1330^20
 ;;^UTILITY(U,$J,358.3,32309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32309,1,3,0)
 ;;=3^Lupus,Erythematosus,Local
 ;;^UTILITY(U,$J,358.3,32309,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,32309,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,32310,0)
 ;;=L93.1^^97^1330^21
 ;;^UTILITY(U,$J,358.3,32310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32310,1,3,0)
 ;;=3^Lupus,Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,32310,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,32310,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,32311,0)
 ;;=M32.0^^97^1330^19
 ;;^UTILITY(U,$J,358.3,32311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32311,1,3,0)
 ;;=3^Lupus,Erythematosus,Drug-Induced Systemic
 ;;^UTILITY(U,$J,358.3,32311,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,32311,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,32312,0)
 ;;=M32.10^^97^1330^22
 ;;^UTILITY(U,$J,358.3,32312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32312,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic
 ;;^UTILITY(U,$J,358.3,32312,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,32312,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,32313,0)
 ;;=M32.19^^97^1330^24
 ;;^UTILITY(U,$J,358.3,32313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32313,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
 ;;^UTILITY(U,$J,358.3,32313,1,4,0)
 ;;=4^M32.19
 ;;^UTILITY(U,$J,358.3,32313,2)
 ;;=^5011759
 ;;^UTILITY(U,$J,358.3,32314,0)
 ;;=M32.9^^97^1330^23
 ;;^UTILITY(U,$J,358.3,32314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32314,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
 ;;^UTILITY(U,$J,358.3,32314,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,32314,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,32315,0)
 ;;=E88.1^^97^1330^17
 ;;^UTILITY(U,$J,358.3,32315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32315,1,3,0)
 ;;=3^Lipodystrophy NOS
 ;;^UTILITY(U,$J,358.3,32315,1,4,0)
 ;;=4^E88.1
 ;;^UTILITY(U,$J,358.3,32315,2)
 ;;=^5003028
 ;;^UTILITY(U,$J,358.3,32316,0)
 ;;=C85.19^^97^1330^2
 ;;^UTILITY(U,$J,358.3,32316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32316,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32316,1,4,0)
 ;;=4^C85.19
 ;;^UTILITY(U,$J,358.3,32316,2)
 ;;=^5001710
 ;;^UTILITY(U,$J,358.3,32317,0)
 ;;=C85.13^^97^1330^5
 ;;^UTILITY(U,$J,358.3,32317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32317,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intra-Abdominal Lymph Nodes
 ;;^UTILITY(U,$J,358.3,32317,1,4,0)
 ;;=4^C85.13
 ;;^UTILITY(U,$J,358.3,32317,2)
 ;;=^5001704
 ;;^UTILITY(U,$J,358.3,32318,0)
 ;;=C85.16^^97^1330^6
 ;;^UTILITY(U,$J,358.3,32318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32318,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,32318,1,4,0)
 ;;=4^C85.16
 ;;^UTILITY(U,$J,358.3,32318,2)
 ;;=^5001707
 ;;^UTILITY(U,$J,358.3,32319,0)
 ;;=C85.12^^97^1330^7
 ;;^UTILITY(U,$J,358.3,32319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32319,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intrathoracic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,32319,1,4,0)
 ;;=4^C85.12
 ;;^UTILITY(U,$J,358.3,32319,2)
 ;;=^5001703
 ;;^UTILITY(U,$J,358.3,32320,0)
 ;;=C85.14^^97^1330^1
 ;;^UTILITY(U,$J,358.3,32320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32320,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,32320,1,4,0)
 ;;=4^C85.14
 ;;^UTILITY(U,$J,358.3,32320,2)
 ;;=^5001705
 ;;^UTILITY(U,$J,358.3,32321,0)
 ;;=C85.11^^97^1330^3
 ;;^UTILITY(U,$J,358.3,32321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32321,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,32321,1,4,0)
 ;;=4^C85.11
 ;;^UTILITY(U,$J,358.3,32321,2)
 ;;=^5001702
 ;;^UTILITY(U,$J,358.3,32322,0)
 ;;=C85.15^^97^1330^4
 ;;^UTILITY(U,$J,358.3,32322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32322,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,32322,1,4,0)
 ;;=4^C85.15
 ;;^UTILITY(U,$J,358.3,32322,2)
 ;;=^5001706
 ;;^UTILITY(U,$J,358.3,32323,0)
 ;;=C85.18^^97^1330^8
 ;;^UTILITY(U,$J,358.3,32323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32323,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,32323,1,4,0)
 ;;=4^C85.18
 ;;^UTILITY(U,$J,358.3,32323,2)
 ;;=^5001709
 ;;^UTILITY(U,$J,358.3,32324,0)
 ;;=C85.17^^97^1330^9
 ;;^UTILITY(U,$J,358.3,32324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32324,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Spleen
 ;;^UTILITY(U,$J,358.3,32324,1,4,0)
 ;;=4^C85.17
 ;;^UTILITY(U,$J,358.3,32324,2)
 ;;=^5001708
 ;;^UTILITY(U,$J,358.3,32325,0)
 ;;=C85.10^^97^1330^10
 ;;^UTILITY(U,$J,358.3,32325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32325,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,32325,1,4,0)
 ;;=4^C85.10
 ;;^UTILITY(U,$J,358.3,32325,2)
 ;;=^5001701
 ;;^UTILITY(U,$J,358.3,32326,0)
 ;;=L60.1^^97^1331^2
 ;;^UTILITY(U,$J,358.3,32326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32326,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,32326,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,32326,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,32327,0)
 ;;=L60.2^^97^1331^1
 ;;^UTILITY(U,$J,358.3,32327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32327,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,32327,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,32327,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,32328,0)
 ;;=B35.1^^97^1331^3
 ;;^UTILITY(U,$J,358.3,32328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32328,1,3,0)
 ;;=3^Onychomycosis
 ;;^UTILITY(U,$J,358.3,32328,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,32328,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,32329,0)
 ;;=L60.3^^97^1331^4
 ;;^UTILITY(U,$J,358.3,32329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32329,1,3,0)
 ;;=3^Onychorrexis/Onychodystrophy
 ;;^UTILITY(U,$J,358.3,32329,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,32329,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,32330,0)
 ;;=L50.8^^97^1332^4
 ;;^UTILITY(U,$J,358.3,32330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32330,1,3,0)
 ;;=3^Urticaria,Other Spec
 ;;^UTILITY(U,$J,358.3,32330,1,4,0)
 ;;=4^L50.8
 ;;^UTILITY(U,$J,358.3,32330,2)
 ;;=^5009203
 ;;^UTILITY(U,$J,358.3,32331,0)
 ;;=L50.0^^97^1332^2
 ;;^UTILITY(U,$J,358.3,32331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32331,1,3,0)
 ;;=3^Urticaria,Allergic
 ;;^UTILITY(U,$J,358.3,32331,1,4,0)
 ;;=4^L50.0
 ;;^UTILITY(U,$J,358.3,32331,2)
 ;;=^5009200
 ;;^UTILITY(U,$J,358.3,32332,0)
 ;;=L50.6^^97^1332^3
 ;;^UTILITY(U,$J,358.3,32332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32332,1,3,0)
 ;;=3^Urticaria,Contact
 ;;^UTILITY(U,$J,358.3,32332,1,4,0)
 ;;=4^L50.6
 ;;^UTILITY(U,$J,358.3,32332,2)
 ;;=^5009202
 ;;^UTILITY(U,$J,358.3,32333,0)
 ;;=L50.2^^97^1332^1
 ;;^UTILITY(U,$J,358.3,32333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32333,1,3,0)
 ;;=3^Urticaria d/t Cold/Heat
 ;;^UTILITY(U,$J,358.3,32333,1,4,0)
 ;;=4^L50.2
 ;;^UTILITY(U,$J,358.3,32333,2)
 ;;=^271938
 ;;^UTILITY(U,$J,358.3,32334,0)
 ;;=L56.3^^97^1332^5
 ;;^UTILITY(U,$J,358.3,32334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32334,1,3,0)
 ;;=3^Urticaria,Solar
 ;;^UTILITY(U,$J,358.3,32334,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,32334,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,32335,0)
 ;;=B02.8^^97^1333^1
 ;;^UTILITY(U,$J,358.3,32335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32335,1,3,0)
 ;;=3^Zoster w/ Other Complications
 ;;^UTILITY(U,$J,358.3,32335,1,4,0)
 ;;=4^B02.8
 ;;^UTILITY(U,$J,358.3,32335,2)
 ;;=^5000500
 ;;^UTILITY(U,$J,358.3,32336,0)
 ;;=B02.9^^97^1333^2
 ;;^UTILITY(U,$J,358.3,32336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32336,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,32336,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,32336,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,32337,0)
 ;;=R45.851^^97^1334^3
 ;;^UTILITY(U,$J,358.3,32337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32337,1,3,0)
 ;;=3^Suicidal Ideations
 ;;^UTILITY(U,$J,358.3,32337,1,4,0)
 ;;=4^R45.851
 ;;^UTILITY(U,$J,358.3,32337,2)
 ;;=^5019474
 ;;^UTILITY(U,$J,358.3,32338,0)
 ;;=T14.91XA^^97^1334^4
 ;;^UTILITY(U,$J,358.3,32338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32338,1,3,0)
 ;;=3^Suicide Attempt,Initial Encntr
 ;;^UTILITY(U,$J,358.3,32338,1,4,0)
 ;;=4^T14.91XA
 ;;^UTILITY(U,$J,358.3,32338,2)
 ;;=^5151779
 ;;^UTILITY(U,$J,358.3,32339,0)
 ;;=T14.91XD^^97^1334^6
 ;;^UTILITY(U,$J,358.3,32339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32339,1,3,0)
 ;;=3^Suicide Attempt,Subsequent Encntr
 ;;^UTILITY(U,$J,358.3,32339,1,4,0)
 ;;=4^T14.91XD
 ;;^UTILITY(U,$J,358.3,32339,2)
 ;;=^5151780
 ;;^UTILITY(U,$J,358.3,32340,0)
 ;;=T14.91XS^^97^1334^5
 ;;^UTILITY(U,$J,358.3,32340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32340,1,3,0)
 ;;=3^Suicide Attempt,Sequela
 ;;^UTILITY(U,$J,358.3,32340,1,4,0)
 ;;=4^T14.91XS
 ;;^UTILITY(U,$J,358.3,32340,2)
 ;;=^5151781
 ;;^UTILITY(U,$J,358.3,32341,0)
 ;;=Z91.51^^97^1334^2
 ;;^UTILITY(U,$J,358.3,32341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32341,1,3,0)
 ;;=3^Personal Hx of Suicidal Behavior
 ;;^UTILITY(U,$J,358.3,32341,1,4,0)
 ;;=4^Z91.51
 ;;^UTILITY(U,$J,358.3,32341,2)
 ;;=^5161317
 ;;^UTILITY(U,$J,358.3,32342,0)
 ;;=Z91.52^^97^1334^1
 ;;^UTILITY(U,$J,358.3,32342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32342,1,3,0)
 ;;=3^Personal Hx of Non-Suicidal Self-Harm
 ;;^UTILITY(U,$J,358.3,32342,1,4,0)
 ;;=4^Z91.52
 ;;^UTILITY(U,$J,358.3,32342,2)
 ;;=^5161318
 ;;^UTILITY(U,$J,358.3,32343,0)
 ;;=Z85.828^^97^1335^1
 ;;^UTILITY(U,$J,358.3,32343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32343,1,3,0)
 ;;=3^S/P Non-Melanoma Skin Cancer
 ;;^UTILITY(U,$J,358.3,32343,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,32343,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,32344,0)
 ;;=Z85.820^^97^1335^2
 ;;^UTILITY(U,$J,358.3,32344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32344,1,3,0)
 ;;=3^S/P Melanoma
 ;;^UTILITY(U,$J,358.3,32344,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,32344,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,32345,0)
 ;;=L57.8^^97^1335^3
 ;;^UTILITY(U,$J,358.3,32345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32345,1,3,0)
 ;;=3^Actinic Damage
 ;;^UTILITY(U,$J,358.3,32345,1,4,0)
 ;;=4^L57.8
 ;;^UTILITY(U,$J,358.3,32345,2)
 ;;=^5009226
 ;;^UTILITY(U,$J,358.3,32346,0)
 ;;=L57.0^^97^1335^4
 ;;^UTILITY(U,$J,358.3,32346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32346,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,32346,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,32346,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,32347,0)
 ;;=D48.5^^97^1335^5
 ;;^UTILITY(U,$J,358.3,32347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32347,1,3,0)
 ;;=3^Neoplasm of Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,32347,1,4,0)
 ;;=4^D48.5
 ;;^UTILITY(U,$J,358.3,32347,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,32348,0)
 ;;=L82.1^^97^1335^6
 ;;^UTILITY(U,$J,358.3,32348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32348,1,3,0)
 ;;=3^Seborrheic Keratosis
 ;;^UTILITY(U,$J,358.3,32348,1,4,0)
 ;;=4^L82.1
 ;;^UTILITY(U,$J,358.3,32348,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,32349,0)
 ;;=L82.0^^97^1335^7
 ;;^UTILITY(U,$J,358.3,32349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32349,1,3,0)
 ;;=3^Inflamed Seborrheic Keratosis
 ;;^UTILITY(U,$J,358.3,32349,1,4,0)
 ;;=4^L82.0
 ;;^UTILITY(U,$J,358.3,32349,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,32350,0)
 ;;=B07.9^^97^1335^8
 ;;^UTILITY(U,$J,358.3,32350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32350,1,3,0)
 ;;=3^Viral Wart
 ;;^UTILITY(U,$J,358.3,32350,1,4,0)
 ;;=4^B07.9
 ;;^UTILITY(U,$J,358.3,32350,2)
 ;;=^5000519
 ;;^UTILITY(U,$J,358.3,32351,0)
 ;;=D22.9^^97^1335^9
 ;;^UTILITY(U,$J,358.3,32351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32351,1,3,0)
 ;;=3^Mole/Melanocytic
 ;;^UTILITY(U,$J,358.3,32351,1,4,0)
 ;;=4^D22.9
 ;;^UTILITY(U,$J,358.3,32351,2)
 ;;=^5002058
 ;;^UTILITY(U,$J,358.3,32352,0)
 ;;=D23.9^^97^1335^10
 ;;^UTILITY(U,$J,358.3,32352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32352,1,3,0)
 ;;=3^Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,32352,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,32352,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,32353,0)
 ;;=D18.01^^97^1335^11
 ;;^UTILITY(U,$J,358.3,32353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32353,1,3,0)
 ;;=3^Angioma
 ;;^UTILITY(U,$J,358.3,32353,1,4,0)
 ;;=4^D18.01
 ;;^UTILITY(U,$J,358.3,32353,2)
 ;;=^267697
 ;;^UTILITY(U,$J,358.3,32354,0)
 ;;=L24.89^^97^1335^12
 ;;^UTILITY(U,$J,358.3,32354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32354,1,3,0)
 ;;=3^Irritant Dermatitis d/t Oth Agents
 ;;^UTILITY(U,$J,358.3,32354,1,4,0)
 ;;=4^L24.89
 ;;^UTILITY(U,$J,358.3,32354,2)
 ;;=^5009135
 ;;^UTILITY(U,$J,358.3,32355,0)
 ;;=L21.8^^97^1335^13
 ;;^UTILITY(U,$J,358.3,32355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32355,1,3,0)
 ;;=3^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,32355,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,32355,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,32356,0)
 ;;=L20.89^^97^1335^14
 ;;^UTILITY(U,$J,358.3,32356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32356,1,3,0)
 ;;=3^Atopic Dermatitis
